1. Benefits and Adverse Events Among Elderly Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: Analysis of the Okayama Lung Cancer Study Group Trial 0007 
Nagio Takigawa, MD, PhD, Katsuyuki Kiura, MD, PhD, Yoshihiko Segawa, MD, PhD, Katsuyuki Hotta, MD, PhD, Akihiko Tamaoki, MD, PhD, Yoshiyuki Tokuda, MD, Takuya Nagata, MD, Kazuhiko Watanabe, MD, Kenichi Gemba, MD, PhD, Tomonori Moritaka, MD, PhD, Naokatsu Horita, MD, PhD, Hiromasa Takeda, MD, Niro Okimoto, MD, PhD, Mitsuhiro Takemoto, MD, PhD, Keitaro Matsuo, MD, PhD, Tetsu Shinkai, MD, PhD, Masahiro Tabata, MD, PhD, Hiroshi Ueoka, MD, PhD, Susumu Kanazawa, MD, PhD, Mitsune Tanimoto, MD, PhD 
Journal of Thoracic Oncology 
Volume 6, Issue 6, Pages (June 2011)
DOI: /JTO.0b013e318213f86a
Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

2. FIGURE 1
Overall survival of patients in the two randomly assigned treatment arms according to age group (younger than 70 years versus 70 years or older).
Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e318213f86a)
Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions